Genome Medical Announces $75.3 Million Funding to Revolutionize Genetic Healthcare Delivery Nationwide

Genome Medical is thrilled to announce that it has successfully raised $75,300,000 in a recent funding round aimed at expanding its critical role in the genetic care landscape. As a premier telegenetics care delivery company, Genome Medical is committed to ensuring that genetics-informed health care is accessible for everyone across the U.S. and Canada. With a mission that resonates deeply in today's health-conscious society, the funds will be utilized to scale our operations, enhance our genetic counseling services, and further develop robust partnerships with health systems, laboratories, and biopharmaceutical companies. Our extensive network of telehealth genetic counselors, each with an average of 10 years of clinical experience, has successfully delivered over 200,000 genetic counseling encounters, making personalized care available at a moment’s notice. Utilizing our nationwide virtual care model, we dramatically reduce patient wait times—from as long as 18 months to just one week—allowing individuals to receive urgent care when it is most needed. The additional funding will enable us to expand our reach, refine existing genomic medicine programs, and support innovative clinical trials that require genetic expertise. With a coverage network that extends to 130 million people, Genome Medical is poised to revolutionize the delivery of genetic care. This funding is not just a financial boost; it represents a significant step toward our goal of ensuring that everyone can have their health informed by genetics, ultimately leading to better health outcomes across diverse patient populations.